Logo image
Role of the Apparent Diffusion Coefficient as a Predictor of Tumor Progression in Patients with Chordoma
Journal article   Open access   Peer reviewed

Role of the Apparent Diffusion Coefficient as a Predictor of Tumor Progression in Patients with Chordoma

T. Sasaki, T. Moritani, A. Belay, A. A. Capizzano, S. P. Sato, Y. Sato, P. Kirby, S. Ishitoya, A. Oya, M. Toda, …
American journal of neuroradiology : AJNR, Vol.39(7), pp.1316-1321
07/01/2018
DOI: 10.3174/ajnr.A5664
PMCID: PMC7655429
PMID: 29724767
url
https://doi.org/10.3174/ajnr.A5664View
Published (Version of record) Open Access

Abstract

BACKGROUND AND PURPOSE: Diffusion-weighted imaging may aid in distinguishing aggressive chordoma from nonaggressive chordoma. This study explores the prognostic role of the apparent diffusion coefficient in chordomas. MATERIALS AND METHODS: Sixteen patients with residual or recurrent chordoma were divided postoperatively into those with an aggressive tumor, defined as a growing tumor having a doubling time of <1 year, and those with a nonaggressive tumor on follow-up MR images. The ability of the ADC to predict an aggressive tumor phenotype was investigated by receiver operating characteristic analysis. The prognostic role of ADC was assessed using a Kaplan-Meier curve with a log-rank test. RESULTS: Seven patients died during a median follow-up of 48 months (range, 4-126 months). Five of these 7 patients were in the aggressive tumor group, and 2 were in the nonaggressive tumor group. The mean ADC was significantly lower in the aggressive tumor group than in the nonaggressive tumor group (P = .002). Receiver operating characteristic analysis showed that a cutoff ADC value of 1.494 x 10(-3) x mm(2)/s could be used to diagnose aggressive tumors with an area under the curve of 0.983 (95% CI, 0.911-1.000), a sensitivity of 1.000 (95% CI, 0.541-1.000), and a specificity of 0.900 (95% CI, 0.555-0.998). Furthermore, a cutoff ADC of 1.494 x 10(-3) x mm(2)/s was associated with a significantly worse prognosis (P = .006). CONCLUSIONS: Lower ADC values could predict tumor progression in postoperative chordomas.
Clinical Neurology Life Sciences & Biomedicine Neuroimaging Neurosciences & Neurology Radiology, Nuclear Medicine & Medical Imaging Science & Technology

Details

Metrics

Logo image